Literature DB >> 28477696

Whipple's disease.

Rima El-Abassi1, Michael Y Soliman2, Frank Williams3, John D England4.   

Abstract

Whipple's disease is a rare, chronic, systemic infectious disorder with prominent intestinal manifestations. It presents with weight loss, arthralgia, diarrhea, and abdominal pain. There are different entities of infection or carriage, respectively, classical Whipple's disease, localized WD, and Isolated Neurological WD. The disease is commonly diagnosed by biopsy of lymph node or small-bowel. Histological detection within duodenal biopsies with "Periodic acid Schiff" (PAS) staining still is first choice for the diagnosis of classical Whipple's disease. PCR or immunohistochemistry can identify the agent more specifically, and DNA sequencing for Tropheryma whipplei on lymphocytes from blood and cerebrospinal fluid from PCR-positive specimens, is essential. Cell-mediated immunity in active and inactive Whipple's disease has subtle defects that might predispose some individuals to symptomatic infection with this bacillus. Successful treatment can be achieved in most of the cases by antimicrobial therapy. WD can be progressive lethal. Immune reconstitution inflammatory syndrome (IRIS) might complicate the course of treatment and in worst case end fatal.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  CNS Whipple disease; Treatment of Whipple disease; Tropheryma whipplei; Whipple disease

Mesh:

Year:  2017        PMID: 28477696     DOI: 10.1016/j.jns.2017.01.048

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  [Chronic Tropheryma whipplei infection: an important differential diagnosis of refractory polyarthritis].

Authors:  Nikolas Ruffer; Marie-Therese Holzer; Yannik Gkanatsas; Izabela Schinglerová; Damir Boro; Martin Krusche; Ina Kötter
Journal:  Z Rheumatol       Date:  2022-04-06       Impact factor: 1.372

Review 2.  The Brief Case: Tropheryma whipplei Infection Resulting in Neurological Symptoms.

Authors:  M H Hyche; P Kent; C M G Schammel; M Devane; S E Fiester; M Call; J Knight
Journal:  J Clin Microbiol       Date:  2022-08-17       Impact factor: 11.677

Review 3.  Clinical manifestations of Whipple's disease mimicking rheumatic disorders.

Authors:  Eugeniusz J Kucharz; Justyna Kramza; Anida Grosicka; Robert Pieczyrak
Journal:  Reumatologia       Date:  2021-04-27

Review 4.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

5.  Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei.

Authors:  Maëlle Le Goff; Divi Cornec; Dewi Guellec; Thierry Marhadour; Valérie Devauchelle-Pensec; Sandrine Jousse-Joulin; Marion Herbette; Jean Michel Cauvin; Clara Le Guillou; Yves Renaudineau; Christophe Jamin; Jacques Olivier Pers; Alain Saraux
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

Review 6.  Rapidly progressive dementia and intractable diarrhea: a teaching case report and a systematic review of cognitive impairment in Whipple's disease.

Authors:  Arianna Manini; Giacomo Querzola; Carlo Lovati; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2022-01-03       Impact factor: 3.307

Review 7.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

8.  Familial Mediterranean Fever Mimicking Whipple's Disease: A Case Report and Review of the Literature.

Authors:  Sofia Flouda; Georgia-Savvina Moysidou; Christina Damoulari; Noemin Kapsala
Journal:  Mediterr J Rheumatol       Date:  2022-06-30

9.  Diagnostic Approach for Classic Compared With Localized Whipple Disease.

Authors:  Nicholas R Crews; Kelly A Cawcutt; Bobbi S Pritt; Robin Patel; Abinash Virk
Journal:  Open Forum Infect Dis       Date:  2018-06-13       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.